articleThe Lancet Respiratory MedicineDec 16, 2014GREEN OA

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial

University of California, San Francisco · Massachusetts General Hospital · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

792
total citations
FWCI
21.69
Percentile
100%
References
39
Citations per year

Authors

18

Topics & keywords

Keywords
  • Medicine
  • ARDS
  • Chest radiograph
  • Adverse effect
  • Mesenchymal stem cell
  • Clinical trial
  • Mechanical ventilation
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding